Literature DB >> 23836860

Flavoproteins are potential targets for the antibiotic roseoflavin in Escherichia coli.

Simone Langer1, Masayuki Hashimoto, Birgit Hobl, Tilo Mathes, Matthias Mack.   

Abstract

The riboflavin analog roseoflavin is an antibiotic produced by Streptomyces davawensis. Riboflavin transporters are responsible for roseoflavin uptake by target cells. Roseoflavin is converted to the flavin mononucleotide (FMN) analog roseoflavin mononucleotide (RoFMN) by flavokinase and to the flavin adenine dinucleotide (FAD) analog roseoflavin adenine dinucleotide (RoFAD) by FAD synthetase. In order to study the effect of RoFMN and RoFAD in the cytoplasm of target cells, Escherichia coli was used as a model. E. coli is predicted to contain 38 different FMN- or FAD-dependent proteins (flavoproteins). These proteins were overproduced in recombinant E. coli strains grown in the presence of sublethal amounts of roseoflavin. The flavoproteins were purified and analyzed with regard to their cofactor contents. It was found that 37 out of 38 flavoproteins contained either RoFMN or RoFAD. These cofactors have different physicochemical properties than FMN and FAD and were reported to reduce or completely abolish flavoprotein function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836860      PMCID: PMC3754745          DOI: 10.1128/JB.00646-13

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  46 in total

Review 1.  Flavoenzymes: diverse catalysts with recurrent features.

Authors:  M W Fraaije; A Mattevi
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  On the reaction mechanism of L-lactate oxidase: quantitative structure-activity analysis of the reaction with para-substituted L-mandelates.

Authors:  K Yorita; K Janko; K Aki; S Ghisla; B A Palfey; V Massey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  On the interpretation of quantitative structure-function activity relationship data for lactate oxidase.

Authors:  K Yorita; H Misaki; B A Palfey; V Massey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

4.  Molecular cloning and characterisation of the ribC gene from Bacillus subtilis: a point mutation in ribC results in riboflavin overproduction.

Authors:  D Coquard; M Huecas; M Ott; J M van Dijl; A P van Loon; H P Hohmann
Journal:  Mol Gen Genet       Date:  1997-03-18

5.  Regulation of riboflavin biosynthesis in Bacillus subtilis is affected by the activity of the flavokinase/flavin adenine dinucleotide synthetase encoded by ribC.

Authors:  M Mack; A P van Loon; H P Hohmann
Journal:  J Bacteriol       Date:  1998-02       Impact factor: 3.490

6.  Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase.

Authors:  S Zenno; H Koike; A N Kumar; R Jayaraman; M Tanokura; K Saigo
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

7.  The flavoenzyme azobenzene reductase AzoR from Escherichia coli binds roseoflavin mononucleotide (RoFMN) with high affinity and is less active in its RoFMN form.

Authors:  Simone Langer; Shinobu Nakanishi; Tilo Mathes; Tanja Knaus; Alexandra Binter; Peter Macheroux; Tomoko Mase; Takuya Miyakawa; Masaru Tanokura; Matthias Mack
Journal:  Biochemistry       Date:  2013-06-10       Impact factor: 3.162

8.  Genome sequence of the bacterium Streptomyces davawensis JCM 4913 and heterologous production of the unique antibiotic roseoflavin.

Authors:  Frank Jankowitsch; Julia Schwarz; Christian Rückert; Bertolt Gust; Rafael Szczepanowski; Jochen Blom; Stefan Pelzer; Jörn Kalinowski; Matthias Mack
Journal:  J Bacteriol       Date:  2012-10-05       Impact factor: 3.490

9.  The flavin reductase activity of the flavoprotein component of sulfite reductase from Escherichia coli. A new model for the protein structure.

Authors:  M Eschenbrenner; J Covès; M Fontecave
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

Review 10.  Riboflavin analogs as antiinfectives: occurrence, mode of action, metabolism and resistance.

Authors:  Danielle Biscaro Pedrolli; Frank Jankowitsch; Julia Schwarz; Simone Langer; Shinobu Nakanishi; Eva Frei; Matthias Mack
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more
  18 in total

1.  Selective small-molecule inhibition of an RNA structural element.

Authors:  John A Howe; Hao Wang; Thierry O Fischmann; Carl J Balibar; Li Xiao; Andrew M Galgoci; Juliana C Malinverni; Todd Mayhood; Artjohn Villafania; Ali Nahvi; Nicholas Murgolo; Christopher M Barbieri; Paul A Mann; Donna Carr; Ellen Xia; Paul Zuck; Dan Riley; Ronald E Painter; Scott S Walker; Brad Sherborne; Reynalda de Jesus; Weidong Pan; Michael A Plotkin; Jin Wu; Diane Rindgen; John Cummings; Charles G Garlisi; Rumin Zhang; Payal R Sheth; Charles J Gill; Haifeng Tang; Terry Roemer
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

2.  Targeting RNA with Small Molecules To Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine.

Authors:  Matthew D Disney
Journal:  J Am Chem Soc       Date:  2019-04-19       Impact factor: 15.419

3.  Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora.

Authors:  Kenneth F Blount; Cynthia Megyola; Mark Plummer; David Osterman; Tim O'Connell; Paul Aristoff; Cheryl Quinn; R Alan Chrusciel; Toni J Poel; Heinrich J Schostarez; Catherine A Stewart; Daniel P Walker; Peter G M Wuts; Ronald R Breaker
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

4.  Roseoflavin, a Natural Riboflavin Analogue, Possesses In Vitro and In Vivo Antiplasmodial Activity.

Authors:  Ayman L Hemasa; Matthias Mack; Kevin J Saliba
Journal:  Antimicrob Agents Chemother       Date:  2022-09-12       Impact factor: 5.938

5.  Uptake and Metabolism of Antibiotics Roseoflavin and 8-Demethyl-8-Aminoriboflavin in Riboflavin-Auxotrophic Listeria monocytogenes.

Authors:  Andreas Matern; Danielle Pedrolli; Stephanie Großhennig; Jörgen Johansson; Matthias Mack
Journal:  J Bacteriol       Date:  2016-11-04       Impact factor: 3.490

6.  A Remarkable Oxidative Cascade That Replaces the Riboflavin C8 Methyl with an Amino Group during Roseoflavin Biosynthesis.

Authors:  Isita Jhulki; Prem K Chanani; Sameh H Abdelwahed; Tadhg P Begley
Journal:  J Am Chem Soc       Date:  2016-06-29       Impact factor: 15.419

7.  A Riboflavin Transporter in Bdellovibrio exovorous JSS.

Authors:  Irina A Rodionova; Fereshteh Heidari Tajabadi; Zhongge Zhang; Dmitry A Rodionov; Milton H Saier
Journal:  J Mol Microbiol Biotechnol       Date:  2019-09-11

8.  Cofactors and pathogens: Flavin mononucleotide and flavin adenine dinucleotide (FAD) biosynthesis by the FAD synthase from Brucella ovis.

Authors:  Andrea Moreno; Victor Taleb; María Sebastián; Ernesto Anoz-Carbonell; Marta Martínez-Júlvez; Milagros Medina
Journal:  IUBMB Life       Date:  2021-11-23       Impact factor: 4.709

9.  An rfuABCD-Like Operon and Its Relationship to Riboflavin Utilization and Mammalian Infectivity by Borrelia burgdorferi.

Authors:  Matthew K Muramatsu; Jianli Zhou; Bryna L Fitzgerald; Ranjit K Deka; John T Belisle; Michael V Norgard
Journal:  Infect Immun       Date:  2021-07-12       Impact factor: 3.441

10.  Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli.

Authors:  Paul Quehl; Joel Hollender; Jan Schüürmann; Tatjana Brossette; Ruth Maas; Joachim Jose
Journal:  Microb Cell Fact       Date:  2016-02-02       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.